Status:
COMPLETED
Vaginal Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients
Lead Sponsor:
Aswan University Hospital
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
To compare the effectiveness of vaginal isonicotinic acid hydrazide with placebo in minimizing the pain experienced by primarily infertile patients during diagnostic office hysteroscopy and to assess t...
Detailed Description
hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, fibroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of a...
Eligibility Criteria
Inclusion
- nulliparous women with primary infertility requiring a diagnostic hysteroscopy as a part of an infertility diagnosis workup
Exclusion
- women with suspected pregnancy
- heavy vaginal bleeding
- recent pelvic infection
- those known to have hypersensitivity or contraindication to isonicotinic acid hydrazide
- those who received analgesics prior to office heavy vaginal bleeding
- recent pelvic infection
- a concomitant neurologic disease that could affect the correct evaluation of pain
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04500522
Start Date
September 1 2020
End Date
September 15 2021
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81528